Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A clinical study of COVID-19 Vaccine (Coronavirus vaccine - Generex Biotechnology)

Trial Profile

A clinical study of COVID-19 Vaccine (Coronavirus vaccine - Generex Biotechnology)

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 09 Mar 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Coronavirus vaccine Generex Biotechnology (Primary)
  • Indications COVID 2019 infections
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Mar 2020 New trial record
    • 02 Mar 2020 According to an Generex Biotechnology Corporation media release, when the optimal vaccine formulation is determined, the company through NGIO intends to initiate the requisite clinical trials of the Ii-Key-nCOV peptide vaccine for approval in the United States.
    • 02 Mar 2020 According to an Generex Biotechnology Corporation media release, the parties activities under the Agreement, including the clinical trials, are subject to approval under China Technology Import Contract Management Regulations as well as the Chinese version of the FDA. The group plans to manufacture multi-valent Ii-Key peptide vaccines for evaluation in human clinical trials in China.
Restricted Access

If your organization has a subscription then there are several options available to help you access AdisInsight while working remotely. Contact us at AsktheExpert.AdisInsight@springer.com to find out more.
Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top